Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hope Theory as Ability Determinant to Permanently Change the Adapted Physical Activity (APA) in Type 2 Diabetic Patients

NCT02733302 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT02733302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02733302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hope Theory as Ability Determinant to Permanently Change the Adapted Physical Activity (APA) in Type 2 Diabetic Patients
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Unknown status
Start date
April 4, 2016
Completion date
September 30, 2019
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes